Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
55.8M
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
8.86M
-
Shares change
-
+7.6M
-
Total reported value, excl. options
-
$177M
-
Value change
-
+$152M
-
Number of buys
-
42
-
Price
-
$20.27
Significant Holders of Foghorn Therapeutics Inc. - COMMON STOCK (FHTX) as of Q4 2020
43 filings reported holding FHTX - Foghorn Therapeutics Inc. - COMMON STOCK as of Q4 2020.
Foghorn Therapeutics Inc. - COMMON STOCK (FHTX) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.86M shares
of 55.8M outstanding shares and own 15.89% of the company stock.
Largest 10 shareholders include FMR LLC (2.58M shares), Euclidean Capital LLC (1.26M shares), Cormorant Asset Management, LP (1M shares), BlackRock Inc. (672K shares), Monashee Investment Management LLC (560K shares), Alphabet Inc. (501K shares), VANGUARD GROUP INC (403K shares), Birchview Capital, LP (314K shares), SUVRETTA CAPITAL MANAGEMENT, LLC (259K shares), and Casdin Capital, LLC (216K shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.